Trade Report: Today, Johnson & Johnson (JNJ) Issues Quarterly Earnings Results

Today, Johnson & Johnson (JNJ) Issues Quarterly  Earnings Results

Johnson & Johnson (NYSE:JNJ) posted its earnings results on Tuesday. The company reported $1.68 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.66 by $0.02. The firm earned $17.80 billion during the quarter, compared to the consensus estimate of $17.71 billion. Johnson & Johnson had a net margin of 20.97% and a return on equity of 24.70%.

Johnson & Johnson (NYSE:JNJ) opened at 118.49 on Tuesday. The company has a market capitalization of $324.17 billion, a PE ratio of 22.08 and a beta of 0.62. The company’s 50-day moving average price is $118.71 and its 200 day moving average price is $117.56. Johnson & Johnson has a 52 week low of $94.28 and a 52 week high of $126.07.

In related news, CAO Ronald A. Kapusta sold 2,935 shares of the business’s stock in a transaction that occurred on Friday, July 22nd. The stock was sold at an average price of $125.01, for a total value of $366,904.35. Following the completion of the sale, the chief accounting officer now directly owns 28,660 shares in the company, valued at approximately $3,582,786.60. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, VP Dominic J. Caruso sold 41,146 shares of the business’s stock in a transaction that occurred on Tuesday, July 26th. The stock was sold at an average price of $125.01, for a total value of $5,143,661.46. Following the completion of the sale, the vice president now owns 157,819 shares of the company’s stock, valued at $19,728,953.19. The disclosure for this sale can be found here. 0.11% of the stock is owned by corporate insiders.

A number of large investors have recently bought and sold shares of the company. Horizon Investments LLC raised its stake in Johnson & Johnson by 0.3% in the second quarter. Horizon Investments LLC now owns 2,349 shares of the company’s stock valued at $285,000 after buying an additional 8 shares during the period. Lbmc Investment Advisors LLC raised its stake in Johnson & Johnson by 0.4% in the second quarter. Lbmc Investment Advisors LLC now owns 3,764 shares of the company’s stock valued at $457,000 after buying an additional 16 shares during the period. Kinsight LLC raised its stake in Johnson & Johnson by 0.5% in the second quarter. Kinsight LLC now owns 3,891 shares of the company’s stock valued at $472,000 after buying an additional 21 shares during the period. Greenwich Wealth Management LLC raised its stake in Johnson & Johnson by 1.1% in the second quarter. Greenwich Wealth Management LLC now owns 2,494 shares of the company’s stock valued at $303,000 after buying an additional 27 shares during the period. Finally, Northeast Financial Consultants Inc raised its stake in Johnson & Johnson by 0.3% in the second quarter. Northeast Financial Consultants Inc now owns 14,992 shares of the company’s stock valued at $1,819,000 after buying an additional 40 shares during the period. Hedge funds and other institutional investors own 65.32% of the company’s stock.

A number of research firms recently issued reports on JNJ. Credit Suisse Group AG reissued a “neutral” rating and set a $123.00 target price on shares of Johnson & Johnson in a research report on Monday, September 19th. Wells Fargo & Co. reissued a “buy” rating on shares of Johnson & Johnson in a research report on Monday, July 11th. BMO Capital Markets reissued an “outperform” rating and set a $132.00 target price on shares of Johnson & Johnson in a research report on Wednesday, July 20th. Zacks Investment Research raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $139.00 target price for the company in a research report on Friday, August 5th. Finally, Vetr raised shares of Johnson & Johnson from a “hold” rating to a “buy” rating and set a $123.13 target price for the company in a research report on Tuesday, September 27th. Two research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and ten have assigned a buy rating to the company. Johnson & Johnson has a consensus rating of “Hold” and an average target price of $120.20.

Johnson & Johnson Company Profile

Related posts

Leave a Comment